miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q. Onco Targets Ther. 2018;11:1501—1509. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The journal was notified of alleged image manipulation relating to Figure 3B. Specifically: Figure 3B panel miR-NC appears to be a duplication, but with more cells added, of Figure 7B panel si-CON group published in Wang et al, 2017 (https://doi.org/10.1159/000480412). The same image has also been observed in other publications, including Figure 11a panel miR-708 mimic, published in Song et al, 2019 (https://doi.org/10.1007/s12253-017-0334-z) and in Figure 8B published in Pan et al, 2018 (RETRACTED) (https://doi.org/10.1159/000487567). The authors were unable to provide a satisfactory explanation for the duplication and the decision was made to retract the paper. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper